Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 276 - 300 of 338 in total
Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass ▼ Formula
Diacylglycerophosphoinositolglycans LMGP15010037
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/18:1(9Z))
126457405 1040.641258 C52H97O18P
Diacylglycerophosphoinositolglycans LMGP15010042
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/18:0)
126457410 1040.641258 C52H97O18P
Diacylglycerophosphoinositolglycans LMGP15010043
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/18:1(9Z))
126457411 1038.625608 C52H95O18P
Diacylglycerophosphoinositolglycans LMGP15010048
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/18:0)
126457416 1038.625608 C52H95O18P
Diacylglycerophosphoinositolglycans LMGP15010049
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/18:1(9Z))
126457417 1036.609958 C52H93O18P
Diacylglycerophosphoinositolglycans LMGP15010018
  • 2'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:0)
126457386 1028.641258 C51H97O18P
Diacylglycerophosphoinositolglycans LMGP15010019
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/18:1(9Z))
126457387 1026.625608 C51H95O18P
Diacylglycerophosphoinositolglycans LMGP15010024
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/18:0)
126457392 1026.625608 C51H95O18P
Diacylglycerophosphoinositolglycans LMGP15010025
  • 2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:1(9Z)/18:1(9Z))
126457393 1024.609958 C51H93O18P
Diacylglycerophosphoinositolglycans LMGP15010030
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/18:0)
126457398 1024.609958 C51H93O18P
Diacylglycerophosphoinositolglycans LMGP15010031
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:2(9Z,12Z)/18:1(9Z))
126457399 1022.594308 C51H91O18P
Diacylglycerophosphoinositolglycans LMGP15010012
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:0)
126457380 1014.625608 C50H95O18P
Diacylglycerophosphoinositolglycans LMGP15010033
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:0)
126457401 1014.625608 C50H95O18P
Diacylglycerophosphoinositolglycans LMGP15010013
  • 2'-O-(alpha-D-Manp)-(1-heptadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(17:0/18:1(9Z))
126457381 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010034
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:1(9Z))
126457402 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010039
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:0)
126457407 1012.609958 C50H93O18P
Diacylglycerophosphoinositolglycans LMGP15010035
  • 2'-O-(alpha-D-Manp)-(1-nonadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:0/16:2(9Z,12Z))
126457403 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010040
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:1(9Z))
126457408 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010045
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:0)
126457413 1010.594308 C50H91O18P
Diacylglycerophosphoinositolglycans LMGP15010041
  • 2'-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:1(9Z)/16:2(9Z,12Z))
126457409 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010046
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z-hexadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:1(9Z))
126457414 1008.578658 C50H89O18P
Diacylglycerophosphoinositolglycans LMGP15010047
  • 2'-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(19:2(9Z,12Z)/16:2(9Z,12Z))
126457415 1006.563008 C50H87O18P
Diacylglycerophosphoinositolglycans LMGP15010006
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:0)
126457374 1000.609958 C49H93O18P
Diacylglycerophosphoinositolglycans LMGP15010015
  • 2'-O-(alpha-D-Manp)-(1-octadecanoyl-2-hexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(18:0/16:0)
126457383 1000.609958 C49H93O18P
Diacylglycerophosphoinositolglycans LMGP15010007
  • 2'-O-(alpha-D-Manp)-(1-hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
  • PIM1(16:0/18:1(9Z))
126457375 998.594308 C49H91O18P

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024